Alexion
Alexion is a global biopharmaceutical company focused on the discovery, development, and commercialization of medicines for severe and life-threatening rare disorders. The company was established in 1992 and is headquartered in Boston, Massachusetts.
Last updated on
About Alexion
Founded
1992Estimated Revenue
$1B-$10BEmployees
5K-10KFunding / Mkt. Cap
$18MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
28NAICs Code
32Location
City
BostonState
MassachusettsCountry
United StatesTech Stack (148)
